Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 6.0B | 6.0B | 6.3B | 6.3B |
| Cost of revenue | 3.5B | 3.7B | 3.6B | 3.6B |
| Gross profit | 2.5B | 2.3B | 2.6B | 2.7B |
| Operating expense | ||||
| Research & development | 285M | 282M | 269M | 280M |
| Selling general and admin | 945M | 899M | 1.1B | 1.1B |
| Other operating expenses | — | — | — | — |
| Operating income | 1.2B | 1.1B | 1.3B | 1.3B |
| Non operating interest income | ||||
| Income | 79M | 92M | 107M | 143M |
| Expense | 255M | 252M | 276M | 322M |
| Other income expense | 315M | -166M | 574M | 317M |
| Pretax income | 1.4B | 759M | 1.7B | 1.4B |
| Tax provision | 265M | 33M | 348M | 203M |
| Net income | 1.1B | 728M | 1.4B | 1.2B |
| Basic EPS | 2.1 | 1.3 | 2.5 | 2.1 |
| Diluted EPS | 2.0 | 1.3 | 2.5 | 2.1 |
| Basic average shares | 543.8M | 543.6M | 550.6M | 553.8M |
| Diluted average shares | 547.7M | 546.3M | 552.7M | 554.8M |
| EBITDA | 1.6B | 1.5B | 1.7B | 920M |
| Net income from continuing op. | 1.1B | 728M | 1.4B | 1.2B |
| Minority interests | -6M | 0 | -4M | -6M |
| Preferred stock dividends | — | — | — | — |